NCT06537440 2025-11-21
Electroacupuncture for Opioid-Induced Constipation in Cancer Patients: A Randomized Clinical Trial
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Phase NA Completed
Clinical Trials
12 trialsNCT05133076 2025-06-26
OIC1
BioGaia Pharma AB
Phase 2 Completed
NCT05149833 2025-04-03
E-StOIC
University of Dublin, Trinity College
Completed
NCT04294550 2022-02-28
Study on Quality of Life in Advanced Cancer Patients With Opioid-induced Constipation Treated With Naloxegol
Fondazione ANT Italia ONLUS
Completed
NCT04404933 2020-05-28
StOIC-2
Royal Surrey County Hospital NHS Foundation Trust
Completed
NCT04350112 2020-04-16
StOIC-1
Royal Surrey County Hospital NHS Foundation Trust
Completed
NCT02270983 2019-04-08
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Forest Laboratories
Phase 2 Completed
NCT01395524 2017-02-23
A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation
AstraZeneca
Phase 3 Completed
NCT00135577 2015-09-02
Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2 Completed
NCT01323790 2015-06-02
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
AstraZeneca
Phase 3 Completed
NCT01309841 2015-06-01
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
AstraZeneca
Phase 3 Completed
NCT00984334 2013-12-27
Naloxone SR Capsules in Patients With Opioid Induced Constipation
S.L.A. Pharma AG
Phase 2 Completed